Aripiprazole-d8 (butyl-d8)
| Product Name | Aripiprazole-d8 (butyl-d8) |
|---|---|
| Alternate Names | Aripiprazole Stable Isotopes, Stable Isotopes of Aripiprazole |
| CAT No. | CS-O-06413 |
| CAS No. | 1089115-04-7 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 456.4 g/mol |
| Mol. For. | C23H19D8Cl2N3O2 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Aripiprazole |
| Purity | Not less than 90 % |
| Canonical Smiles | C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl |
| InchIKey | CEUORZQYGODEFX-BQLKVSHCSA-N |
| Inchl | InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)/i1D2,2D2,10D2,15D2 |
| IUPAC | 7-[1,1,2,2,3,3,4,4-octadeuterio-4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Aripiprazole-d8 (butyl-d8) is a deuterated form of aripiprazole, a medication used primarily to treat schizophrenia, bipolar disorder, and major depressive disorder. Aripiprazole-d8 (butyl-d8) is a selective dopamine D2 receptor partial agonist, meaning it can both activate and block dopamine receptors in the brain. This unique property makes it effective at treating the positive symptoms of schizophrenia, such as hallucinations and delusions, as well as the negative symptoms, such as apathy and social withdrawal.
Aripiprazole-d8 (butyl-d8) is administered orally in the form of tablets or injections. The deuterium substitution in butyl-d8 makes it useful in pharmacokinetic studies, as it allows researchers to track the drug's metabolism and distribution in the body.
The chemical formula of aripiprazole-d8 (butyl-d8) is C23H22D8ClN3O2, with a molecular weight of 410.04 g/mol. It is classified as an atypical antipsychotic, which means that it has a lower risk of causing movement disorders (such as tardive dyskinesia) than older antipsychotic medications.
While aripiprazole-d8 (butyl-d8) has demonstrated efficacy in treating a variety of psychiatric disorders, it does carry some potential side effects. These can include insomnia, nausea, dizziness, and weight gain. As with any medication, it is important to consult with a healthcare provider to determine if aripiprazole-d8 (butyl-d8) is an appropriate treatment option.
Get an Instant Quote
Related Compounds
Aripiprazole-d8 (piperazine-d8) | Aripiprazole (D8) | Dehydro Aripiprazole D8 (piperazine-d8) |